Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 102NETWORK 10INDUSTRY 8OTHER_GOV 2NIH 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1CNS 1

Conditions

Neoplasms 1Liver Neoplasms 1Liver Diseases 1Hemianopsia 1Colorectal Neoplasms 1Brain Neoplasms 1

Interventions

Bevacizumab 5Capecitabine 3toripalimab 2olaparib 2durvalumab 2darolutamide 2atezolizumab 2apatinib 2anlotinib 2Standard of Care 2Radiotherapy 2Radiosurgery 2Oxaliplatin 2Leucovorin 2Laparoscopy 2Immunotherapy 2Fluorouracil 2Drug Therapy 2130-nm albumin-bound paclitaxel 2trametinib 1spartalizumab 1pyrotinib 1pomalidomide 1palbociclib 1nilotinib 1ledipasvir, sofosbuvir drug combination 1ledipasvir 1irinotecan sucrosofate 1hetrombopag 1glasdegib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER_GOV × Standard of Care × 90 days × Clear all
NCT07602504 2026-05-22

China Metastatic Liver Cancer Clinical Registry Cohort Database

Anhui Provincial Hospital

Recruiting
2,000 enrolled
Gastrointestinal

Liver Diseases, Liver Neoplasms, Neoplasms, Colorectal Neoplasms

NCT07558395 2026-04-30

REVIIH-BT

Institut National de la Santé Et de la Recherche Médicale, France

Phase NA Not yet recruiting
120 enrolled
CNS

Brain Neoplasms, Hemianopsia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡